Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Sterrx
AddedFeb 15, 2024
UpdatedJun 18, 2026
Sterrx

Sterrx

Sterrx: A pharmaceutical company specializing in automated, sterile liquid drug manufacturing and packaging.

HQ
Plattsburgh, NY, US
Founded
2013
Overview
Compare
Fundraising
Employees

Sterrx is a pharmaceutical company specializing in automated, sterile liquid drug manufacturing and packaging. Utilizing blow fill seal technology, Sterrx eliminates virtually all human contact in the manufacturing and packaging processes through robotic automation. The company fills vials, syringes, and infusion bags, distributing its products across the United States and Canada.

Sterrx has achieved significant advancements in pharmaceutical manufacturing, ensuring high standards of sterility and efficiency. Their innovative use of robotic automation in blow fill seal technology has set them apart in the industry. The company's impact is evident in its wide distribution network and commitment to maintaining stringent quality controls.

Sterrx - Similar Companies

Staq Pharma logo

Staq Pharma

staqpharma.com

Selkirk Pharma logo

Selkirk Pharma

selkirkpharma.com

Pctrx logo

Pctrx

Asteres logo

Asteres

asteres.com

SteriDev logo

SteriDev

steridev.com

US Specialty Formulations logo

US Specialty Formulations

Pharmabox logo

Pharmabox

pharmabox.com

American Injectables logo

American Injectables

americaninj.com

Vitae Industries logo

Vitae Industries

Multiply Labs logo

Multiply Labs

multiplylabs.com

Advanced Robotics logo

Advanced Robotics

ApiJect Systems logo

ApiJect Systems

apiject.com

STERIS logo

STERIS

steris.com

Continuity Pharma logo

Continuity Pharma

Sterilucent logo

Sterilucent

sterilucent.com

Sterrx - Quick Facts

Who are Sterrx's competitors?

Companies similar to Sterrx include Staq Pharma, Selkirk Pharma, Pctrx and Asteres.

When was Sterrx founded?

Sterrx was founded in 2013.

Where is Sterrx's headquarters located?

Sterrx's headquarters is located in Plattsburgh, NY, US.

When was Sterrx's last funding round?

Sterrx's most recent funding round was for $15M (USD) in September 2017.

How much has Sterrx raised to-date?

As of Sep 21, 2017, Sterrx has raised a total of $15M (USD).

How many employees does Sterrx have?

Sterrx has 71 employees as of Feb 5, 2024.

Sterrx - Classification

Ownership
  • Private
Technology
  • Automation
  • Robotics
Geographic Exposure
  • United States
Model
  • Manufacturing
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Drug Manufacturing
  • Pharmaceuticals
Tags
  • Biotech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations